Ursolic Acid: Assay Method; Source Material and the Specification That Hides Both

A label declares a standardised ursolic acid content and the assay method behind it is left unstated. Two suppliers can both be truthful and still deliver material that behaves differently in a capsule.

This note is for buyers and formulators sourcing ursolic acid for supplements and cosmetic actives. It covers what the percentage standardisation actually means, how the source material changes the result, and the checks that keep a specification honest.

Ursolic acid is sold as a standardised percentage, and the assay method behind that number decides what you bought

The molecule is the same whether it comes from apple peel, rosemary leaf or a fermentation route. The matrix around it is not.

A forty percent extract and a ninety-eight percent extract are different products, with different uses, different costs, different handling requirements and different documentation attached to them.

Comparing them on price per kilogram is meaningless until the percentage and the method are fixed in the specification.

The assay method matters as much as the result

HPLC against a certified reference is the method most buyers assume. Titration and UV methods appear in certificates too, and they do not distinguish ursolic acid from closely related triterpenoids.

A UV result can read high because the related compounds absorb in the same region. The certificate is not wrong, it is answering a different question.

Ask for the chromatogram, not only the number. A supplier who can send one is working at a different level of control.

Source material sets the impurity profile

Apple peel extract carries a different set of co-extracted compounds than rosemary, and those compounds affect colour, taste and stability in the finished product.

For a capsule, taste is irrelevant and colour matters little. For a beverage or a cosmetic emulsion, both become formulation problems.

The source should be named in the specification for that reason, not simply described as botanical origin.

Solubility is the constraint that decides which dosage form is possible

Ursolic acid is poorly soluble in water, which rules out simple aqueous formats and pushes formulators toward suspensions, emulsions or lipid systems.

That is a formulation fact rather than a quality defect, and a supplier claiming water solubility should be asked for the system used to achieve it.

Micronisation and carriers change dissolution rate but not the underlying solubility. The distinction matters when a bioavailability claim is being made.

Adulteration is common in high-percentage botanical extracts

Where a premium is paid for a high assay, there is an incentive to spike material with a cheaper source of the same molecule.

Stable isotope or botanical marker testing can establish whether the material came from the plant claimed. Most certificates do not include it.

For a product making a botanical claim, the marker profile is part of the identity of the ingredient itself. Buying on assay alone leaves that identity unprotected.

Heavy metals and pesticide residues follow the agricultural source

Leaf material concentrates what the plant took up, and orchard material carries the residues of whatever was applied to the trees.

A specification written for a fermentation-derived ingredient will not protect a buyer switching to a botanical extract of the same assay.

Testing frequency should follow the source risk rather than the purchase value, and it should be stated in the quality agreement.

Particle size and flow decide whether the capsule line runs

A fine powder with poor flow causes weight variation on a capsule filler that was set up for a granulated material.

Milling to a defined particle size distribution, or specifying a granulated grade, solves a problem that no assay will reveal.

Ask for the particle size distribution and a bulk density figure. Both are cheap to provide and both predict how the material behaves on the line.

Stability is a colour and potency question at the same time

Triterpenoids oxidise slowly, and the change shows first as a colour shift that nobody records, and later as a potency loss that appears on the certificate.

Accelerated stability data tells you how fast that happens, and it is the only basis for setting a retest period rather than guessing one.

Packaging matters here more than most buyers expect. Moisture ingress drives the reaction, and a foil laminate is worth considerably more than a longer shelf life claimed on paper.

Incoming inspection for a botanical extract should be tiered

Identity and assay on every lot, heavy metals and microbiology on a fixed schedule, and marker or isotope testing only when a source change has been declared by the supplier.

Writing the tiers into the supplier agreement means the response to a failed result is agreed before the failure arrives.

The cosmetic active ingredient side of the business has run this playbook longer, and the specification language transfers directly.

Where the ingredient is used changes the specification entirely

A supplement grade needs the identity and safety documentation that a food authority expects, including the novel food position for the source.

A cosmetic grade needs the safety assessment and the declared function, and it may tolerate a lower assay at a lower cost.

The ursolic acid buyer who writes one specification for both uses will pay for purity they cannot sell and miss documentation they need.

Fermentation routes are changing what the supply base looks like

Producing the molecule by fermentation rather than extraction gives a more consistent assay and removes the agricultural variability that botanical sourcing carries.

It also removes the botanical identity, which matters if the product being sold makes a plant-based claim on the label.

The two routes are not interchangeable in a regulatory file, even when the certificate of analysis looks comparable, because the dossier describes a manufacturing process and not only a molecule.

Documentation requirements differ by destination market

A supplement ingredient entering one market may need a novel food assessment, while the same material enters another as an established botanical with a monograph.

The supplier's dossier is usually written for the market they sell into most, and it may not answer the question your regulator asks.

Checking the dossier against your own market before ordering is cheaper than discovering the gap after the first shipment clears customs.

Switching grades carries a cost that never appears on the quotation

Moving from a forty percent extract to a ninety-eight percent one changes the dose per capsule, the flow behaviour and the stability profile at once.

The reformulation work, the new stability study and the label change are all real costs, and they usually exceed the difference in ingredient price.

Buyers who compare only the price per kilogram tend to switch twice, and they pay the reformulation cost both times without ever seeing it on a purchase order.

FAQ: questions buyers ask

Is a higher percentage always better?

No. High assay costs more and may bring poorer flow or lower bulk density. The right percentage depends on the dose per capsule and on what the rest of the formula can tolerate.

Why do two certificates for the same product show different assays?

Because they use different methods. UV methods include related triterpenoids that HPLC separates, so the same material can read higher on one certificate than the other.

How can I tell if an extract is adulterated?

By marker or isotope testing against the claimed botanical source. Assay alone cannot distinguish a genuine extract from one fortified with the same molecule from a cheaper source.

Does particle size really matter for a capsule?

Yes. Fine powders flow poorly and cause weight variation on equipment set up for granulated material. Particle size distribution and bulk density predict this before the first batch runs.

What is a reasonable retest period?

Whatever the accelerated stability data supports, with packaging taken into account. A period copied from a supplier without data behind it is a commercial convenience rather than a control.